Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
Experimental Hematology|December 29, 2016
Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effectGuillermo Orti, Pere Barba, Laura Fox, et al.
British Journal of Haematology|November 20, 2013
B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRILGerardo Ferrer, Rosa Bosch, Kate Hodgson, et al.
Blood|August 26, 2010
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significanceCarol Moreno, Kate Hodgson, Gerardo Ferrer, et al.
Blood|September 21, 2006
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlationsKostas Stamatopoulos, Chrysoula Belessi, Carol Moreno, et al.
Medicina Clinica|November 9, 2007
[Autologous haematopoietic stem cell transplantation in POEMS syndrome: results in 4 cases]Pau Abrisqueta, Montserrat Rovira, María Teresa Cibeira, et al.
Blood|November 2, 2002
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemiaMíriam Molina-Arcas, Beatriz Bellosillo, F Javier Casado, et al.
Blood|October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemiaPau Abrisqueta, Neus Villamor, María José Terol, et al.
Oncotarget|December 30, 2014
Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivoNoelia Purroy, Pau Abrisqueta, Júlia Carabia, et al.
Leukemia & Lymphoma|January 5, 2013
MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemiaGerardo Ferrer, Alfons Navarro, Kate Hodgson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signalingGaël Roué, Mónica López-Guerra, Pierre Milpied, et al.
Pageof 27